Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Eye irritation

Currently viewing:

Administrative data

Endpoint:
eye irritation: in vivo
Type of information:
experimental study
Adequacy of study:
key study
Study period:
From 09 March 2015 to 30 March 2015
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: The study was conclusive, performed to a valid guideline (OECD TG 405, adopted 2 October 2012) and was conducted under GLP conditions. No deviations from the test methods were noted.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2015
Report date:
2015

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 405 (Acute Eye Irritation / Corrosion)
Deviations:
no
Qualifier:
according to guideline
Guideline:
EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Remarks:
Date of GLP inspection: 12 to 14 March 2015 Date of Signature on Certificate: 12 May 2015

Test material

Constituent 1
Chemical structure
Reference substance name:
Polyphosphoric acids, ammonium salts
EC Number:
269-789-9
EC Name:
Polyphosphoric acids, ammonium salts
Cas Number:
68333-79-9
Molecular formula:
[NH4PO3]n
IUPAC Name:
undecaammonium bis(phosphonatooxy)phosphinate dihydrogen phosphate hydrogen (phosphonatooxy)phosphonate hydrogen phosphate
Test material form:
solid: particulate/powder
Remarks:
migrated information: powder
Details on test material:
- Name of test material (as cited in study report): Polyphosphoric acids, ammonium salts (solid)
- Physical state: white powder
- Analytical purity: 100%
- Lot/batch No.: MD141010
- Expiration date of the lot/batch: 14 October 2015
- Storage condition of test material: room temperature in the dark

Test animals / tissue source

Species:
rabbit
Strain:
New Zealand White
Details on test animals or tissues and environmental conditions:
TEST ANIMALS
- Source: Harlan Laboratoires UK Ltd., Leicestershire, UK
- Age at study initiation: 12 to 20 weeks old
- Weight at study initiation: 2.95 or 3.12 kg
- Housing: Individually in suspended cages
- Diet (e.g. ad libitum): 2930C Teklad Global Rabbit diet supplied by Harlan Laboratories UK Ltd., Oxon, UK was supplied ad libitum
- Water (e.g. ad libitum): Mains drinking water provided ad libitum.
- Acclimation period: At least five days

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23
- Humidity (%): 30 to 70
- Air changes (per hr): At least fifteen per hour
- Photoperiod (hrs dark / hrs light): 12 hours dark/12 hours light

Test system

Vehicle:
unchanged (no vehicle)
Controls:
other: The left eye of each animal remained untreated and was used for control purposes.
Amount / concentration applied:
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL, approx 84 mg (as measured by gently compacting the required volume into an adapted syringe)


Observation period (in vivo):
Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment.
Number of animals or in vitro replicates:
Two - after consideration of the ocular responses produced in the first treated animal, a second animal was similarly treated.
Details on study design:
ANALGESIA
A subcutaneous injection of buprenorphine 0.01 mg/kg was administered 60 minutes prior to test item application to provide a therapeutic level of systemic analgesia. Five minutes prior to test item application, a pre-dose anesthesia of ocular anesthetic (two drops of 0.5% tetracaine hydrochloride) was applied to each eye.

Eight hours after test item application, a subcutaneous injection of post-dose analgesia, buprenorphine 0.01 mg/kg and meloxicam 0.5 mg/kg, was administered to provide a continued therapeutic level of systemic analgesia. The treated animal was checked for signs of pain and suffering approximately 12 hours later. No further analgesia was required.

TEST PROCEDURE
The test item was placed into the conjunctival sac of the right eye, formed by gently pulling the lower lid away from the eyeball. The upper and lower eyelids were held together for about one second immediately after treatment, to prevent loss of the test item, and then released. Immediately after administration of the test item, an assessment of the initial pain reaction was made according to the six point scale shown in Appendix 1.

REMOVAL OF TEST SUBSTANCE
- Washing (if done): None

SCORING SYSTEM: Assessment of ocular damage/irritation was made approximately 1 hour and 24, 48 and 72 hours following treatment according to the Draize scale (Appendix 2).

TOOL USED TO ASSESS SCORE: Standard opthalmascope

Results and discussion

In vivo

Resultsopen allclose all
Irritation parameter:
cornea opacity score
Basis:
animal: 74927 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
0
Max. score:
4
Reversibility:
other: not applicable
Irritation parameter:
cornea opacity score
Basis:
animal: 75004
Time point:
other: Mean 24, 48 and 72 hours
Score:
0
Max. score:
4
Reversibility:
other: not applicable
Irritation parameter:
iris score
Basis:
animal: 74927 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
0.33
Max. score:
2
Reversibility:
fully reversible within: 48 hours
Irritation parameter:
iris score
Basis:
animal: 75004 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
0.33
Max. score:
2
Reversibility:
fully reversible within: 48 hours
Irritation parameter:
other: redness
Basis:
animal: 74927 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
2
Max. score:
3
Reversibility:
fully reversible within: 7 days
Irritation parameter:
other: redness
Basis:
animal: 75004 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
2
Max. score:
3
Reversibility:
fully reversible within: 7 days
Irritation parameter:
chemosis score
Basis:
animal: 74927 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
1.67
Max. score:
4
Reversibility:
fully reversible within: 7 days
Irritation parameter:
chemosis score
Basis:
animal: 75004 Male
Time point:
other: Mean 24, 48 and 72 hours
Score:
1.67
Max. score:
4
Reversibility:
fully reversible within: 7 days
Irritant / corrosive response data:
Individual scores for ocular irritation are given in Table 1. Individual and Mean Scores for Cornea, Iris and Conjunctivae required for classification and labelling are given in Table 2.
No corneal effects were noted during the study.
Iridial inflammation was noted in both treated eyes 1 and 24 hours after treatment.
Moderate conjunctival irritation was noted in all treated eyes 1 hour after treatment and at the 24 and 48-Hour observations with minimal conjunctival irritation noted at the 72-Hour observation.
Both treated eyes appeared normal at the 7-Day observation.
Other effects:
Individual body weights and body weight change are given in Table 3.
Both animals showed expected gain in body weight during the study.

Any other information on results incl. tables

Table 1: Individual Scores for Ocular Irritation

Rabbit Number and Sex

74927Male

75004 Male

Initial Pain Response = 0

Initial Pain Response = 0

Time After Treatment

1 Hour

24 Hours

48 Hours

72 Hours

7 Days

1 Hour

24 Hours

48 Hours

72 Hours

7 days

CORNEA

 

 

 

 

 

 

 

 

 

 

Degree of Opacity

0

0

0

0

0

0

0

0

0

0

Area of Cornea Involved

0

0

0

0

0

0

0

0

0

0

IRIS

1

1

0

0

0

1

1

0

0

0

CONJUNCTIVAE

 

 

 

 

 

 

 

 

 

 

Redness

2

2

2

2

0

2

2

2

2

0

Chemosis

2

2

2

1

0

2

2

2

1

0

Discharge

1

1

0

0

0

2

2

1

0

0

Table 2 Individual and Mean Scores for Cornea, Iris and Conjunctivae

Rabbit Number and Sex

Time After Treatment

Corneal Opacity

Iridial Inflammation

Conjuctival Redness

Conjunctival Chemosis

 

74927 Male

24 Hours

0

1

2

2

48 Hours

0

0

2

2

72 Hours

0

0

2

1

Mean

0.0

0.3

2.0

1.7

 

75004 Male

24 Hours

0

1

2

2

48 Hours

0

0

2

2

72 Hours

0

0

2

1

Mean

0.0

0.3

2.0

1.7

Table 3 Individual Bodyweights and Bodyweight Change

Table 3 Individual Bodyweights and Bodyweight Change

Rabbit Number and Sex

Individual Bodyweight (kg)

Bodyweight Change (kg)

Day 0

Day 7

74927 Male

3.12

3.18

0.06

75004 Male

2.95

3.00

0.05

 

Applicant's summary and conclusion

Interpretation of results:
Category II
Remarks:
Migrated information Criteria used for interpretation of results: EU
Conclusions:
The test item produced individual scores of 0.0 for corneal opacity, 0.3 for iritis, 2.0 for conjunctival redness and 1.7 for chemosis, calculated as the mean scores following grading at 24, 48 and 72 hours after instillation. Observed effects were fully reversible within the observation period.

The test item was classified as Category 2B (mildly irritating to eyes) according to the Globally Harmonized System of Classification and Labelling of Chemicals.

The test item was also classified as Irritating to eyes (Category 2) according to Regulation (EC) No. 1272/2008, relating to the Classification, Labelling and Packaging of Substances and Mixtures.
Executive summary:

Introduction

The study was performed to assess the irritancy potential of the test item to the eye of the New Zealand White rabbit.

Results

A single application of the test item to the non-irrigated eye of two rabbits produced iridial inflammation and moderate conjunctival irritation. Both treated eyes appeared normal at the 7-Day observation.

Conclusion

The test item produced individual scores of 0.0 for corneal opacity, 0.3 for iritis, 2.0 for conjunctival redness and 1.7 for chemosis, calculated as the mean scores following grading at 24, 48 and 72 hours after instillation. Observed effects were fully reversible within the observation period. The test item was classified as Category 2B (mildly irritating to eyes) according to the Globally Harmonized System of Classification and Labelling of Chemicals.

The test item was also classified as Irritating to eyes (Category 2) according to Regulation (EC) No. 1272/2008, relating to the Classification, Labelling and Packaging of Substances and Mixtures. It is reasonable to assume that the Signal Word “Warning” and the Hazard Statement “H319: Causes serious eye irritation” are therefore required